$0.2130
-0.0155-6.78%
Últ. Act.: Oct 30, 6:12 PM
20/20 Biolabs (AIDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | FY '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.12 | $-0.10 | — |
| Actual | $-0.26 | $-0.28 | $-0.76 |
| Surprise | -116.7% | -180.0% | — |
| Revenue | |||
| Estimate | $636000 | $779000 | — |
| Actual | $730571 | $353375 | $2.0M |
| Surprise | +14.9% | -54.6% | — |
| Metric | Q3 '26E | FY '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.06 | $-0.42 |
| Revenue | ||
| Consensus | $891000 | $2.9M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.26 | $-0.12 | -116.7 % |
| Q1 | May 20, 2026 | $-0.28 | $-0.10 | -180.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $730.57K | $636.00K | 14.9 % |
| Q1 | May 20, 2026 | $353.38K | $779.00K | -54.6 % |